Mesa Laboratories (MLAB) News Today $124.64 +2.75 (+2.26%) Closing price 03/27/2025 04:00 PM EasternExtended Trading$124.61 -0.03 (-0.02%) As of 03/27/2025 04:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Gary M. Owens Sells 21,000 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) StockMesa Laboratories, Inc. (NASDAQ:MLAB - Get Free Report) CEO Gary M. Owens sold 21,000 shares of the company's stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $123.91, for a total value of $2,602,110.00. Following the sale, the chief executive officer now directly owns 43,337 shares of the company's stock, valued at approximately $5,369,887.67. This represents a 32.64 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.March 25 at 4:31 PM | marketbeat.comMesa Laboratories, Inc. (NASDAQ:MLAB) Shares Sold by Boston PartnersBoston Partners trimmed its holdings in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 44.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 4,627 shares of the medical instruments supplier's stock after selling 3,726 shares durMarch 23, 2025 | marketbeat.comVictory Capital Management Inc. Sells 5,165 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB)Victory Capital Management Inc. decreased its holdings in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 36.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,836 shares of the medicaMarch 20, 2025 | marketbeat.comMesa Laboratories, Inc. (NASDAQ:MLAB) Shares Sold by Royce & Associates LPRoyce & Associates LP decreased its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 17.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 287,207 shares of the medical instruments sMarch 17, 2025 | marketbeat.comDiamond Hill Capital Management Inc. Takes $3.51 Million Position in Mesa Laboratories, Inc. (NASDAQ:MLAB)Diamond Hill Capital Management Inc. purchased a new position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 26,634 shares of the medical instrumenMarch 16, 2025 | marketbeat.com247,795 Shares in Mesa Laboratories, Inc. (NASDAQ:MLAB) Purchased by Raymond James Financial Inc.Raymond James Financial Inc. purchased a new position in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 247,795 shares of the medical insMarch 14, 2025 | marketbeat.comGeneva Capital Management LLC Cuts Stake in Mesa Laboratories, Inc. (NASDAQ:MLAB)Geneva Capital Management LLC reduced its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 1.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 189,013 shares of the medical instrumentsMarch 7, 2025 | marketbeat.comMesa Laboratories, Inc. (NASDAQ:MLAB) Position Increased by Principal Financial Group Inc.Principal Financial Group Inc. grew its holdings in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 9.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 38,359 shares of the medical instruments supplier's stock after purchasing aMarch 4, 2025 | marketbeat.comMesa Laboratories (NASDAQ:MLAB) Sees Large Volume Increase - Should You Buy?Mesa Laboratories (NASDAQ:MLAB) Sees Large Volume Increase - Time to Buy?March 1, 2025 | marketbeat.comAllspring Global Investments Holdings LLC Trims Position in Mesa Laboratories, Inc. (NASDAQ:MLAB)Allspring Global Investments Holdings LLC decreased its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 66.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,553 shares of the medicalFebruary 26, 2025 | marketbeat.comCalculating The Intrinsic Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)February 21, 2025 | uk.finance.yahoo.comMesa Laboratories (NASDAQ:MLAB) Shares Cross Above 200-Day Moving Average - Time to Sell?Mesa Laboratories (NASDAQ:MLAB) Stock Price Passes Above Two Hundred Day Moving Average - Here's What HappenedFebruary 19, 2025 | marketbeat.comMesa Laboratories, Inc. (NASDAQ:MLAB) Shares Bought by Rice Hall James & Associates LLCRice Hall James & Associates LLC raised its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 25.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 27,668 shares of the medical instruments suppFebruary 19, 2025 | marketbeat.comWhat Makes Mesa Laboratories (MLAB) a Valuable Stock?February 13, 2025 | insidermonkey.comMesa Laboratories (NASDAQ:MLAB) Reaches New 1-Year High - Here's What HappenedMesa Laboratories (NASDAQ:MLAB) Sets New 52-Week High - What's Next?February 11, 2025 | marketbeat.comWells Fargo Sticks to Their Sell Rating for Mesa Laboratories (MLAB)February 10, 2025 | markets.businessinsider.comAnalysts Conflicted on These Technology Names: Workday (WDAY) and Mesa Laboratories (MLAB)February 7, 2025 | markets.businessinsider.comKeyBanc maintains Mesa Labs stock Sector Weight ratingFebruary 5, 2025 | msn.comMesa Laboratories (NASDAQ:MLAB) Stock, Short Interest ReportFebruary 5, 2025 | benzinga.comMesa Laboratories (NASDAQ:MLAB) Sets New 1-Year High on Earnings BeatMesa Laboratories (NASDAQ:MLAB) Reaches New 1-Year High After Earnings BeatFebruary 5, 2025 | marketbeat.comRecap: Mesa Laboratories Q3 EarningsFebruary 4, 2025 | benzinga.comMesa Laboratories (NASDAQ:MLAB) Stock Price Up 12.3% Following Strong EarningsMesa Laboratories (NASDAQ:MLAB) Trading Up 12.3% After Earnings BeatFebruary 4, 2025 | marketbeat.comMesa Laboratories (NASDAQ:MLAB) Releases Earnings Results, Beats Estimates By $0.66 EPSMesa Laboratories (NASDAQ:MLAB - Get Free Report) posted its quarterly earnings data on Tuesday. The medical instruments supplier reported $2.07 EPS for the quarter, beating the consensus estimate of $1.41 by $0.66. Mesa Laboratories had a positive return on equity of 28.52% and a negative net margin of 107.56%.February 4, 2025 | marketbeat.comMesa Labs reports Q3 EPS (31c) vs. 39c last yearFebruary 4, 2025 | markets.businessinsider.comMesa Laboratories Non-GAAP EPS of $2.72 beats by $1.21, revenue of $62.84M beats by $4.01MFebruary 4, 2025 | seekingalpha.comMesa Labs Announces Third Quarter ResultsFebruary 4, 2025 | globenewswire.comConestoga Capital Advisors LLC Grows Stake in Mesa Laboratories, Inc. (NASDAQ:MLAB)Conestoga Capital Advisors LLC lifted its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 8.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 573,037 shares of the medical instruments supplFebruary 3, 2025 | marketbeat.comMesa Laboratories (MLAB) to Release Quarterly Earnings on MondayMesa Laboratories (NASDAQ:MLAB) will be releasing earnings before the market opens on Monday, February 3, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=657517)January 27, 2025 | marketbeat.comJPMorgan Chase & Co. Has $1.09 Million Stake in Mesa Laboratories, Inc. (NASDAQ:MLAB)JPMorgan Chase & Co. raised its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 29.3% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 8,406 shares of the medical instruments supplier's stock aftJanuary 25, 2025 | marketbeat.comMesa Labs stock soars to 52-week high of $149.5 amid robust growthJanuary 24, 2025 | msn.comMesa Laboratories (NASDAQ:MLAB) Stock Price Down 4.8% - What's Next?Mesa Laboratories (NASDAQ:MLAB) Trading Down 4.8% - What's Next?January 23, 2025 | marketbeat.comMesa Laboratories (NASDAQ:MLAB) Reaches New 52-Week High - Should You Buy?Mesa Laboratories (NASDAQ:MLAB) Reaches New 52-Week High - Here's What HappenedJanuary 21, 2025 | marketbeat.comMesa Laboratories, Inc. to Announce Third Quarter Results on February 4, 2025January 17, 2025 | globenewswire.comBarclays PLC Has $1.15 Million Stock Holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB)Barclays PLC raised its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 357.4% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 8,837 shares of the medical instruments supplier's stock after buying an addiJanuary 14, 2025 | marketbeat.comJane Street Group LLC Decreases Position in Mesa Laboratories, Inc. (NASDAQ:MLAB)Jane Street Group LLC lowered its stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 89.7% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,308 shares of the medical instruments suJanuary 10, 2025 | marketbeat.comMesa Laboratories, Inc. (NASDAQ:MLAB) Plans Quarterly Dividend of $0.16Mesa Laboratories, Inc. (NASDAQ:MLAB) declared a quarterly dividend on Tuesday, January 7th. Stockholders of record on Friday, February 28th will be given a dividend of 0.16 per share by the medical instruments supplier on Monday, March 17th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.46%. The ex-dividend date is Friday, February 28th.January 7, 2025 | marketbeat.comMESA LABS DECLARES QUARTERLY DIVIDENDJanuary 6, 2025 | globenewswire.comMesa Laboratories (NASDAQ:MLAB) Sets New 1-Year High - What's Next?Mesa Laboratories (NASDAQ:MLAB) Hits New 1-Year High - Should You Buy?January 6, 2025 | marketbeat.comMesa Laboratories, Inc. (NASDAQ:MLAB) Stock Position Lifted by Principal Financial Group Inc.Principal Financial Group Inc. boosted its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 21.8% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 35,107 shares of the medical insJanuary 3, 2025 | marketbeat.comGeode Capital Management LLC Acquires 5,771 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB)Geode Capital Management LLC grew its stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 4.8% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 124,761 shares of the medical instruments supplier's stock after acquiring an adDecember 30, 2024 | marketbeat.comBarclays PLC Purchases 6,905 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB)Barclays PLC lifted its position in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 357.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 8,837 shares of the medical instruments supplier's stock after acquiring an additDecember 30, 2024 | marketbeat.comMesa Laboratories (NASDAQ:MLAB) Stock Price Down 3.1% - Here's What HappenedMesa Laboratories (NASDAQ:MLAB) Trading Down 3.1% - Here's What HappenedDecember 24, 2024 | marketbeat.comState Street Corp Raises Stock Position in Mesa Laboratories, Inc. (NASDAQ:MLAB)State Street Corp increased its holdings in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 9.2% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 214,148 shares of the medical instruments supplier'sDecember 23, 2024 | marketbeat.comMeros Investment Management LP Has $4.32 Million Stock Holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB)Meros Investment Management LP grew its position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 17.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 33,240 shares of the medical inDecember 11, 2024 | marketbeat.comMesa Laboratories, Inc. (NASDAQ:MLAB) Stock Holdings Boosted by Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc. raised its position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 38.6% in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 62,609 shares of the medical instrumenDecember 11, 2024 | marketbeat.comJanus Henderson Group PLC Has $10.15 Million Position in Mesa Laboratories, Inc. (NASDAQ:MLAB)Janus Henderson Group PLC lessened its stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 31.4% during the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 78,194 shares of the medical instruments supplier's stock after sellinDecember 9, 2024 | marketbeat.comVictory Capital Management Inc. Acquires 6,643 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB)Victory Capital Management Inc. boosted its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 90.3% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 14,001 shares of the medical instruments suppNovember 25, 2024 | marketbeat.comEagle Asset Management Inc. Raises Holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB)Eagle Asset Management Inc. boosted its stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 10.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 165,955 shares of the medical instrumeNovember 23, 2024 | marketbeat.comSegall Bryant & Hamill LLC Has $2.66 Million Holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB)Segall Bryant & Hamill LLC decreased its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 23.8% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,470 shares of the medicalNovember 23, 2024 | marketbeat.comMesa Laboratories (NASDAQ:MLAB) Stock Price Up 9.3% - Here's What HappenedMesa Laboratories (NASDAQ:MLAB) Stock Price Up 9.3% - What's Next?November 22, 2024 | marketbeat.com Remove Ads Get Mesa Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for MLAB and its competitors with MarketBeat's FREE daily newsletter. Email Address MLAB Media Mentions By Week MLAB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MLAB News Sentiment▼0.910.78▲Average Medical News Sentiment MLAB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MLAB Articles This Week▼42▲MLAB Articles Average Week Remove Ads Get Mesa Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for MLAB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies DAKT News FARO News VPG News COHR News BMI News CGNX News ITRI News OSIS News SENS News HURC News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MLAB) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersA $6.9 Trillion Cash Tsunami Is Coming – Move Your Money NOWExpert: "Prepare For the Mother of All Melt-Ups" In the wake of Wall Street volatility, stock-picking legen...Stansberry Research | SponsoredElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredAI Boom Takes a Shocking Turn…A potentially historic moment for retirement Let's make the most of this market together. Crypto 101 Media | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mesa Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mesa Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MLAB Stock Free MLAB Stock Alerts